Vera Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Vera Therapeutics, Inc. (VERA) had Operating Leases, Future Minimum Payments, Due in Three Years of $2.82 million as of 2021-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2023-03-28
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $2.82M.
- 2021-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.46M.
- 2021-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.46M.
- 2021-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $2.46M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2021-12-31 | $2.82M 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.46M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.46M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.46M 10-Q · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |